CDH1 and hepatocellular carcinoma: This study showed that knocking down AHSA1 in two typical HCC cell lines, HepG2, and HCCLM3 resulted in downregulation of the mesenchymal markers, N-cadherin and vimentin, and the upregulation of the epithelial marker E-cadherin.